Physician profile
Robert A Steinberg
NPI 1568524544
$3,053.83
in general payments reported to CMS, 2019-2025
37 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,050 · 2020: $268 · 2021: $517 · 2022: $323 · 2023: $332 · 2024: $163 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $308.85 | 2019-2021 | |
| Amgen INC. | $297.71 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $259.56 | 2021-2023 | Qulipta |
| Merck Sharp & Dohme LLC | $205.12 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $187.93 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $174.12 | 2019-2025 | Breztri |
| Abbott Laboratories | $162.52 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $147.34 | 2019-2025 | Rybelsus, Ozempic |
| Intuitive Surgical, INC. | $144.95 | 2019-2025 | |
| Lilly USA, LLC | $138.65 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $132.73 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Sumitomo Pharma America, INC. | $77.82 | 2024-2025 | Gemtesa |
| Amarin Pharma, INC. | $74.40 | 2019-2021 | |
| Kvk-Tech, INC. | $67.03 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $66.86 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $60.58 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $58.05 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $51.45 | 2024-2025 | Rexulti |
| Boston Scientific Corporation | $46.18 | 2019-2023 | Watchman Flx |
| Sanofi Pasteur INC. | $41.85 | 2020-2025 | |
| Relievant Medsystems, INC. | $38.48 | 2023 | Intracept |
| Astellas Pharma US INC | $38.36 | 2019-2024 | Veozah |
| Allergan, INC. | $35.26 | 2019-2020 | |
| Genentech USA, INC. | $31.29 | 2021-2022 | |
| Coloplast Corp | $22.16 | 2020 | |
| Phathom Pharmaceuticals, INC. | $21.79 | 2025 | Voquezna |
| Abiomed | $17.26 | 2023 | Impella |
| Medtronic, INC. | $17.24 | 2025 | Interstim |
| Biogen, INC. | $17.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.84 | 2022 | |
| Organogenesis INC. | $15.08 | 2021 | |
| Esperion Therapeutics, INC. | $14.33 | 2021 | |
| Alkermes, INC. | $14.17 | 2020 | |
| Dexcom, INC. | $14.00 | 2025 | Dexcom G6 Transmitter |
| Avanir Pharmaceuticals, INC. | $13.18 | 2019 | |
| Seqirus USA INC | $12.85 | 2019 | |
| Eisai INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.